DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

[1]  M. López‐Fraga,et al.  APRIL modulates B and T cell immunity. , 2002, The Journal of clinical investigation.

[2]  D. Schatz,et al.  Somatic Hypermutation of Immunoglobulin Genes Merging Mechanisms for Genetic Diversity , 2002, Cell.

[3]  F. Alt,et al.  The Mechanism and Regulation of Chromosomal V(D)J Recombination , 2002, Cell.

[4]  T. Honjo,et al.  The AID enzyme induces class switch recombination in fibroblasts , 2002, Nature.

[5]  Virginia Pascual,et al.  Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.

[6]  T. Honjo,et al.  A hallmark of active class switch recombination: Transcripts directed by I promoters on looped-out circular DNAs , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Honjo,et al.  In situ class switching and differentiation to IgA-producing cells in the gut lamina propria , 2001, Nature.

[8]  T. Honjo,et al.  Human genetic defects in class-switch recombination (hyper-IgM syndromes). , 2001, Current opinion in immunology.

[9]  J. Tschopp,et al.  BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF , 2001, Science.

[10]  M. Scott,et al.  An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway , 2001, Science.

[11]  Antonio Lanzavecchia,et al.  Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.

[12]  S. Dillon,et al.  TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. , 2001, Immunity.

[13]  R. Zinkernagel,et al.  IgA production without μ or δ chain expression in developing B cells , 2001, Nature Immunology.

[14]  J. V. van Deursen,et al.  Regulation of the T-independent humoral response by TACI. , 2001, Immunity.

[15]  F. Belardelli,et al.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.

[16]  P. Casali,et al.  Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells , 2001, Nature Immunology.

[17]  J. Tschopp,et al.  A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member April, Inhibits Tumor Cell Growth , 2000, The Journal of experimental medicine.

[18]  T. Honjo,et al.  T-Independent immune response: new aspects of B cell biology. , 2000, Science.

[19]  M. Tourigny,et al.  Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response , 2000, The Journal of experimental medicine.

[20]  Tom Boone,et al.  APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity , 2000, Nature Immunology.

[21]  J. Tschopp,et al.  Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population , 2000, The Journal of experimental medicine.

[22]  J. Treanor,et al.  Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell Regulation , 2000, The Journal of experimental medicine.

[23]  J. Cyster.  B cells on the front line , 2000, Nature Immunology.

[24]  V. Dixit,et al.  Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity , 2000, Nature Immunology.

[25]  R. Zinkernagel,et al.  A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. , 2000, Science.

[26]  Don Foster,et al.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.

[27]  I. Maclennan,et al.  Germinal Centers without T Cells , 2000, The Journal of experimental medicine.

[28]  J. Tschopp,et al.  Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.

[29]  Amy S Orr,et al.  BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. , 1999, Science.

[30]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[31]  J. Tschopp,et al.  BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth , 1999, The Journal of experimental medicine.

[32]  J. Tschopp,et al.  APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth , 1998, The Journal of experimental medicine.

[33]  P. Casali,et al.  CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells. , 1998, Immunity.

[34]  R. Welsh,et al.  T-cell-independent antiviral antibody responses. , 1998, Current opinion in immunology.

[35]  N. Harindranath,et al.  CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. , 1998, Journal of immunology.

[36]  R. Bram,et al.  NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. , 1997, Science.

[37]  J. Banchereau,et al.  Human Dendritic Cells Skew Isotype Switching of CD40-activated Naive B Cells towards IgA1 and IgA2 , 1997, The Journal of experimental medicine.

[38]  David D. Chaplin,et al.  Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers , 1996, Science.

[39]  J. Banchereau,et al.  Generation of memory B cells and plasma cells in vitro , 1995, Science.

[40]  R. Paxton,et al.  IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. , 1995, Journal of immunology.

[41]  A. Fischer,et al.  T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand , 1994, The Journal of experimental medicine.

[42]  R J Armitage,et al.  Humoral immune responses in CD40 ligand-deficient mice , 1994, The Journal of experimental medicine.

[43]  R. Flavell,et al.  Mice deficient for the CD40 ligand. , 1994, Immunity.

[44]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[45]  F. Alt,et al.  Mechanism and control of class-switch recombination. , 2002, Trends in immunology.

[46]  P. Moore,et al.  Synthesis and release of B-lymphocyte stimulator from myeloid cells. , 2001, Blood.

[47]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[48]  J. Stavnezer.  Antibody class switching. , 1996, Advances in immunology.

[49]  C. Snapper,et al.  T cell-independent antigens type 2. , 1995, Annual review of immunology.